Dr. Corey J. Langer is a medical oncologist and Director of Thoracic Oncology at the Penn Medicine Abramson Cancer Center in Philadelphia, Pennsylvania. He specializes in the treatment of patients diagnosed with lung cancers and pleural mesothelioma and is particularly effective in the use of targeted treatment protocols that combine radiation therapy and immunotherapeutic drugs.
Dr. David Harpole is a thoracic surgeon whose areas of expertise include mesothelioma surgery, lung cancer surgery, surgery for congenital and acquired chest wall abnormalities, and esophageal cancer surgery at the Duke Cancer Institute in Durham, North Carolina. He specializes in minimally invasive thoracic surgery. Education and Career Dr. Harpole earned his medical degree at
Dr. Luis J. Herrera is a thoracic surgeon and the Medical Director of the Rod Taylor Thoracic Care Center at the Orlando Health Cancer Institute. He specializes in the surgical treatment of tumors of the chest, including pleural mesothelioma, lung cancer, and cancers of the esophagus, mediastinum, and chest wall. Education and Career Dr.
Dr. Amin Mirhadi is a radiation oncologist and the Radiation Oncology Director of the Thoracic Oncology Disease Research Group. at Cedars Sinai in Los Angeles, California. He is part of the multidisciplinary mesothelioma and lung cancer team and also provides his expertise in radiation therapy to the treatment of general pulmonology patients, colon cancer patients,
Dr. Sally York is a medical oncologist and research scientist whose primary clinical focus is on treating patients with lung cancer, thymic cancers, mesothelioma, and other thoracic malignancies. She practices at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Institute, where she is an Assistant Professor of Medicine. She is also the Associate Director for Clinical
Dr. Joel Neal is a thoracic oncologist who treats patients with lung cancer, pleural mesothelioma, and other thoracic malignancies at the Stanford Cancer Institute in Palo Alto, California. He also designs clinical trials, which focus on overcoming acquired resistance to targeted therapies, understanding and improving the efficacy of immunotherapy, and applying circulating tumor DNA technology.
Dr. Horn is a medical oncologist and researcher, and Senior Vice President for Late Development Oncology at AstraZeneca. Speaking of her work, she says, “Recent research has helped us better understand lung cancer biology and our approach to targeted therapy, immunotherapy, and ADCs, individualizing therapy for more patients and addressing mechanisms of resistance. I’m excited
Dr. Fadi S. Braiteh is a medical oncologist at Comprehensive Cancer Centers of Nevada. Board-certified in Medical Oncology, Internal Medicine, and Palliative Medicine, he specializes in the treatment of gastrointestinal and digestive system cancers, breast cancer, and thoracic malignancies, including lung cancer and pleural mesothelioma. Education and Career Dr. Braiteh earned his medical degree from
Dr. Anita Lyn Sabichi is a medical oncologist at the Baylor College of Medicine, the Dan L. Duncan Comprehensive Cancer Center, and the Michael E. DeBakey VA Medical Center in Houston, Texas. She works to carry the results of her translational biology and molecular medicine research into patient treatment in order to create the most
Dr. Scott Antonia is a recognized leader in the research and clinical application of immunotherapy for the treatment of pleural mesothelioma and lung cancer. He practices at the Duke Cancer Institute (DCI), is a member of the Duke Human Vaccine Institute, and is the Director of the DCI Center for Cancer Immunotherapy. Dr. Antonia is